These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2383920

  • 1. High performance liquid chromatography methods for studying protein binding of aluminium in human serum in the absence and in the presence of desferrioxamine.
    García Alonso JI, López García A, Pérez Parajón J, Blanco González E, Sanz Medel A, Cannata JB.
    Clin Chim Acta; 1990 Jul; 189(1):69-79. PubMed ID: 2383920
    [Abstract] [Full Text] [Related]

  • 2. Aluminium and silicon speciation in human serum by lon-exchange high-performance liquid chromatography-electrothermal atomic absorption spectrometry and gel electrophoresis.
    Wróbel K, González EB, Wróbel K, Sanz-Medel A.
    Analyst; 1995 Mar; 120(3):809-15. PubMed ID: 7741232
    [Abstract] [Full Text] [Related]

  • 3. Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).
    Fernández-Martín JL, Menéndez-Fraga P, Canteros MA, Díaz-López JB, Cannata-Andía JB.
    Clin Chim Acta; 1994 Oct 31; 230(2):137-45. PubMed ID: 7834865
    [Abstract] [Full Text] [Related]

  • 4. Quantitative studies of aluminium binding species in human uremic serum by fast protein liquid chromatography coupled with electrothermal atomic absorption spectrometry.
    Soldado Cabezuelo AB, Blanco González E, Sanz-Medel A.
    Analyst; 1997 Jun 31; 122(6):573-7. PubMed ID: 9282403
    [Abstract] [Full Text] [Related]

  • 5. Indirect micro-scale method for the determination of desferrioxamine and its aluminium and iron chelated forms in biological samples by atomic absorption spectrometry with electrothermal atomisation.
    Allain P, Mauras Y, Beaudeau G, Hingouet P.
    Analyst; 1986 May 31; 111(5):531-3. PubMed ID: 3740423
    [No Abstract] [Full Text] [Related]

  • 6. Aluminum-binding serum proteins: desferrioxamine alters serum aluminum speciation.
    Favarato M, Mizzen CA, Sutherland MK, Krishnan B, Kruck TP, McLachlan DR.
    Clin Chim Acta; 1992 Apr 30; 207(1-2):41-55. PubMed ID: 1591866
    [Abstract] [Full Text] [Related]

  • 7. Affinity of the aluminium binding protein.
    Rahman H, Skillen AW, Ward MK, Channon SM, Kerr DN.
    Int J Artif Organs; 1986 Mar 30; 9(2):93-6. PubMed ID: 3699915
    [Abstract] [Full Text] [Related]

  • 8. [The effect of desferrioxamine in aluminum-processing workers].
    Hosovski E, Vidaković A.
    Srp Arh Celok Lek; 1990 Mar 30; 118(9-10):341-5. PubMed ID: 2102549
    [Abstract] [Full Text] [Related]

  • 9. Ultrafiltrable aluminium after very low doses of desferrioxamine.
    Canteros A, Díaz-Corte C, Fernández-Martín JL, Gago E, Fernández-Merayo C, Cannata J.
    Nephrol Dial Transplant; 1998 Jun 30; 13(6):1538-42. PubMed ID: 9641189
    [Abstract] [Full Text] [Related]

  • 10. Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
    Menéndez-Fraga P, Fernández-Martín JL, Blanco-González E, Cannata-Andía JB.
    Clin Chem; 1998 Jun 30; 44(6 Pt 1):1262-8. PubMed ID: 9625051
    [Abstract] [Full Text] [Related]

  • 11. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981 Jun 30; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 12. Aluminium binding to serum constituents: a role for transferrin and for citrate.
    van Ginkel MF, van der Voet GB, van Eijk HG, de Wolff FA.
    J Clin Chem Clin Biochem; 1990 Jul 30; 28(7):459-63. PubMed ID: 2230664
    [Abstract] [Full Text] [Related]

  • 13. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure.
    Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ.
    Toxicol Sci; 2001 Nov 30; 64(1):77-82. PubMed ID: 11606803
    [Abstract] [Full Text] [Related]

  • 14. The determination of ferric iron in plants by HPLC using the microbial iron chelator desferrioxamine E.
    Fernández V, Winkelmann G.
    Biometals; 2005 Feb 30; 18(1):53-62. PubMed ID: 15865410
    [Abstract] [Full Text] [Related]

  • 15. Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
    Van Landeghem GF, D'Haese PC, Lamberts LV, Barata JD, De Broe ME.
    Nephrol Dial Transplant; 1997 Aug 30; 12(8):1692-8. PubMed ID: 9269651
    [Abstract] [Full Text] [Related]

  • 16. Binding affinity of aluminium to human serum transferrin and effects of carbohydrate chain modification as studied by HPLC/high-resolution ICP-MS--speciation of aluminium in human serum.
    Nagaoka MH, Maitani T.
    J Inorg Biochem; 2005 Sep 30; 99(9):1887-94. PubMed ID: 16139893
    [Abstract] [Full Text] [Related]

  • 17. Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium.
    Altmann P, Plowman D, Marsh F, Cunningham J.
    Lancet; 1988 May 07; 1(8593):1012-5. PubMed ID: 2896867
    [Abstract] [Full Text] [Related]

  • 18. Protein binding of aluminium in normal subjects and in patients with chronic renal failure.
    Rahman H, Channon SM, Skillen AW, Ward MK, Kerr DN.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985 May 07; 21():360-5. PubMed ID: 3991523
    [Abstract] [Full Text] [Related]

  • 19. Identification of aluminium fractions in serum using the techniques of high performance liquid chromatography, ultrafiltration and Zeeman atomic absorption spectrometry.
    Röllin HB, Nogueira CM.
    Eur J Clin Chem Clin Biochem; 1997 Mar 07; 35(3):215-22. PubMed ID: 9127743
    [Abstract] [Full Text] [Related]

  • 20. Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disorders.
    Kruck TP, Kalow W, McLachlan DR.
    J Chromatogr; 1985 May 31; 341(1):123-30. PubMed ID: 4019677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.